Prognosis for stage 1 breast cancer
Description of the video
Breast Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute In MP Ian Gibson , chairman of the House of Commons of the United Kingdom all party group on cancer stated "The treatment has been skewed by the lobbying , there is no doubt about that. A meta-analysis of 88 clinical trials involving 62, women with hormone receptor—positive breast cancer who were disease free after 5 years of endocrine therapy showed a steady risk of late recurrence 5 to 20 years after diagnosis cited Pan et al. Since breast cancer in males is usually detected at later stages, outcomes are typically worse. An international consensus panel proposed a risk classification system and systemic therapy treatment options. HER2-positive breast cancer is more aggressive and more likely to spread than HER2-negative breast cancer. Doctors use different prognostic and predictive factors for newly diagnosed and recurrent breast cancers.
Share in a social network